Cellular therapy is the transplantation of human cells to replace or repair damaged tissue and/or cells. With new technologies and innovative products, many different types of cells can be used as part of a therapy/treatment for a variety of diseases and conditions. Moreover, cell-based therapies hold great potential for replacing, repairing, restoring, and/or regenerating damaged tissues, cells, and/or organs. Thus, there is an increase in demand for cell-based therapies.
For instance, in May 2022, The European Commission (EC) approved Janssen’s CAR-T therapy, Carvykti, for adults with heavily pre-treated, relapsed and refractory multiple myeloma, marking the treatment’s first approval outside of the U.S. Moreover, in May 2022, The U.S. Food and Drug Administration (FDA) approved Novartis’s Kymriah (CAR) T-cell therapy) for the treatment of cancer. It remains the only CAR-T cell therapy approved for both adult and pediatric patients.
Market Dynamics:
Increase in incidence/prevalence of chronic diseases, growing adoption of regenerative medicine, rise in focus on the development of cell therapies, increasing number of clinical trials, and outbreak of COVID-19 across the globe is expected to drive growth of the global cell therapy market.For instance, in May 2022, The European Commission (EC) approved Janssen’s CAR-T therapy, Carvykti, for adults with heavily pre-treated, relapsed and refractory multiple myeloma, marking the treatment’s first approval outside of the U.S. Moreover, in May 2022, The U.S. Food and Drug Administration (FDA) approved Novartis’s Kymriah (CAR) T-cell therapy) for the treatment of cancer. It remains the only CAR-T cell therapy approved for both adult and pediatric patients.
Key Features of the Study:
- This report provides in-depth analysis of the global cell therapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cell therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Stempeutics Research Pvt. Ltd., Medipost Co. Ltd., Nipro Corporation, Dendreon Pharmaceuticals LLC, Organogenesis Inc., Novartis AG, Vericel Corporation, Allogene Therapeutics Inc., Gilead Sciences Inc. (Kite Pharma Inc.), and Takeda Pharmaceutical Company Limited (TiGenix).
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy market.
Detailed Segmentation:
Global Cell Therapy Market, By Type:
- Autologous
- Allogeneic
Global Cell Therapy Market, By Therapy:
- Mesenchymal Stem Cell Therapy
- Fibroblast Cell Therapy
- Hematopoietic Stem Cell Therapy
- Other Therapies
Global Cell Therapy Market, By Application:
- Musculoskeletal
- Malignancies
- Cardiovascular
- Dermatology and Wounds
- Other Applications
Global Cell Therapy Market, By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Company Profiles:
- Stempeutics Research Pvt. Ltd.
- Medipost Co. Ltd.
- Nipro Corporation
- Dendreon Pharmaceuticals LLC
- Organogenesis Inc.
- Novartis AG
- Vericel Corporation
- Allogene Therapeutics Inc.
- Gilead Sciences Inc. (Kite Pharma Inc.)
- Takeda Pharmaceutical Company Limited (TiGenix)
Table of Contents
1. Research Objectives and Assumptions- Research Objectives
- Assumptions
- Abbreviations
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Therapy
- Market Snapshot, By Application
- Market Snapshot, By Geography
- Publisher Opportunity Map (COM)
- Market Dynamics
- Increase in incidence/prevalence of chronic diseases
- High cost of cell-based therapies
- Increase focus on the development of novel therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Mesenchymal Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Fibroblast Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Hematopoietic Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Other Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Malignancies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Cardiovascular, Dermatology and Wounds, and Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Dermatology and Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Stempeutics Research Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medipost Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dendreon Pharmaceuticals LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organogenesis Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allogene Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences Inc. (Kite Pharma Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited (TiGenix)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
- Research Methodology
- About the Author
Companies Mentioned
A selection of companies mentioned in this report includes:
- Stempeutics Research Pvt. Ltd.
- Medipost Co. Ltd.
- Nipro Corporation
- Dendreon Pharmaceuticals LLC
- Organogenesis Inc.
- Novartis AG
- Vericel Corporation
- Allogene Therapeutics Inc.
- Gilead Sciences Inc. (Kite Pharma Inc.)
- Takeda Pharmaceutical Company Limited (TiGenix)
